Currently, we know if you stop the medicine the weight does tend to come back just like many other chronic health conditions like blood pressure
Semaglutide's data are built on over 25,000 participants across more than 20 randomized controlled trials, including the largest cardiovascular outcomes trial ever conducted for an anti-obesity medication
Patient Suitability Retatrutide is an investigational new treatment for non-diabetic weight loss
Search strategy and study selection We conducted a comprehensive systematic search across five electronic databases: PubMed, Embase, Web of Science, Scopus, and the Cochrane Library, as well as the Google Scholar search engine, from inception to September 30, 2025, to identify studies investigating the association between GLP-1 receptor agonists and AUD outcomes
the point is to let the gut adapt
However, if vomiting persists or prevents you from eating, see your doctor as soon as possible